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Abstract
Background: While intracellular buffers are widely used to study calcium signaling, no such tool exists for the other major
second messenger, cyclic AMP (cAMP).
Methods/Principal Findings: Here we describe a genetically encoded buffer for cAMP based on the high-affinity cAMP-
binding carboxy-terminus of the regulatory subunit RIb of protein kinase A (PKA). Addition of targeting sequences
permitted localization of this fragment to the extra-nuclear compartment, while tagging with mCherry allowed
quantification of its expression at the single cell level. This construct (named ‘‘cAMP sponge’’) was shown to selectively
bind cAMP in vitro. Its expression significantly suppressed agonist-induced cAMP signals and the downstream activation of
PKA within the cytosol as measured by FRET-based sensors in single living cells. Point mutations in the cAMP-binding
domains of the construct rendered the chimera unable to bind cAMP in vitro or in situ. Cyclic AMP sponge was fruitfully
applied to examine feedback regulation of gap junction-mediated transfer of cAMP in epithelial cell couplets.
Conclusions: This newest member of the cAMP toolbox has the potential to reveal unique biological functions of cAMP,
including insight into the functional significance of compartmentalized signaling events.
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Introduction
Cyclic adenosine 39,5 9-monophosphate (cAMP) has long been
regarded as a ‘‘simple’’ freely diffusible second messenger, well-
known for its ability to modulate multiple cellular functions such as
motility, secretion, growth, metabolism, and synaptic plastici-
ty[1,2]. Classically, cAMP signals are initiated by the binding of a
specific extracellular ligand to a G-protein-coupled receptor
(GPCR) that is linked to a heterotrimeric G-protein containing a
Gas subunit. The ensuing activation of transmembrane adenylyl
cyclases results in the production of cAMP. However, the binding
of a single ligand to a hormone receptor can set into motion a
complex ramifying cascade of signal transduction events that form
unpredictable, nonlinear signaling networks[3]. For example, in
many cases, a single GPCR is able to interact simultaneously with
more than one class of Ga subunit (Gai/o,G aq/11,o rG a12/13),
generating multiple signals inside the cell. Furthermore, the beta-
gamma subunits of heterotrimeric G-proteins, which dissociate
following receptor activation, have their own set of biological
activities (e.g. modulation of plasma membrane ion channels).
Understanding which biological actions are specifically attribut-
able to cAMP amongst all these possible intermediates has
presented a longstanding challenge in the signal transduction
field[4].
In addition, recent data have revealed an unexpected degree of
organizational and spatial complexity in the cAMP signal at the
single cell level, showing the existence of localized cAMP-
dependent signaling events. For example, soluble isoforms of
adenylyl cyclase and localized phosphodiesterases have been
linked to the generation of cAMP microdomains, forcing us to
re-evaluate the traditional concept that this messenger serves as a
straightforward ‘‘on-off’’ switch throughout the bulk cyto-
plasm[5,6,7,8]. New efforts are now directed at determining
whether cAMP microdomains, located for example, within the
nucleus, mitochondria, and sub-plasma membrane compartments,
are subject to independent and unique modes of regulation.
Unfortunately the lack of tools to selectively perturb these
subcellular domains has presented a significant obstacle to
understanding the potential biological role of localized cAMP
signaling events.
The ability to ‘‘buffer’’ cAMP in the cytosol and in specific
microdomains might help to resolve these issues. We therefore
examined whether it is possible to exploit the high-affinity cAMP-
binding portions of the regulatory subunits of protein kinase A
(PKA) as a molecular approach for controlling intracellular
elevations of cAMP. PKA is the primary effector of the cAMP
signal, and consists of two catalytic subunits (PKA-C) bound non-
covalently to a dimer of regulatory subunits (PKA-R). Cyclic AMP
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PKA-R subunit dimer (with four cAMP molecules bound) and two
active C monomers. There are two classes of PKA regulatory
subunits (RI and RII) and each of these exist as two subtypes, a
and b. The RI subunits have the highest affinity for cAMP and
consequently give rise to PKA holoenzymes with lower thresholds
of activation as compared to the PKA-RII holoenzymes [2,9]. The
first 100 amino acids (aa) of PKA-RI contain the biologically active
domains responsible for homo-dimerization and binding to the
PKA-C subunit while the two cAMP binding domains are located
in the carboxy terminus [2,10].
In the present study we describe a targeted high-affinity cAMP
buffer based on the carboxy-terminal cAMP-binding fragment of the
regulatory subunit RIb. Over-expression of this ‘‘cAMP sponge’’ was
ableto buffer agonist-induced cAMP signalsasmeasured atthesingle
cell level and also blocked the downstream activation of PKA. Finally
we used this tool to show that cells without the buffer serve as a source
of cAMP when coupled via gap junctions to cells harboring the
cAMP sponge, and produce extra cAMP to compensate for the extra
buffering power provided by the sponge construct.
Results
Generation of the cAMP Sponge and of a cAMP-Resistant
Mutant Version
We cloned the PKA-RIb C-terminus (AA 133–380), purposely
omitting the PKA catalytic inhibitory domain located at N-
terminus (AA 90–100). This construct binds cAMP with high
affinity, but is unable to generate dimers or bind PKA-C [11]. By
labeling our chimera with the red fluorescent protein, mCherry (a
gift of Roger Tsien[12]) we generated a non-targeted ‘‘cAMP
sponge’’ construct. The addition of targeting motifs permitted
localization to nuclear, plasma membrane, and cytosolic (i.e. non-
nuclear) compartments. We extensively characterized this latter
cytosolic construct, bearing the N-terminal nuclear exclusion
signal (NES: ALPPLERTLTL). As a control, we also generated a
mutant version of this protein unable to bind cAMP called ‘‘mut-
NES-cAMP sponge’’ in which four point mutations were
introduced, two per each of the cAMP binding sites[2] (Figure 1).
We assessed the expression of our constructs by western blots
from total lysates of NCM460[13] cells (a human colonic epithelial
cell line) transiently expressing these chimeras. Bands of the
expected molecular weights (<60 kD) were detected using either a
PKA-RIb specific antibody (Figure 2a), or one that recognized
mCherry (Figure 2b). We noted that the PKA-RIb antibody also
reacted with a second set of bands (<35 kD) likely attributed to
extraction-dependent proteolysis of the full-length expressed
protein[14]. Confocal imaging of live NCM460 cells expressing
the three different cAMP sponge constructs showed similar
expression levels as measured by mCherry intensity and the
expected subcellular distribution (i.e. non-targeted vs. nuclear
exclusion; Figure 2c).
The cAMP Sponge Binds In Vitro cAMP While Its Mutant
Version Does Not
The PKA-RI cAMP binding domains are known to be stable
structures that bind cAMP when separated from the rest of the
protein[2,10,11]. In order to confirm that the ability to bind
cAMP was retained in the chimeric sponge proteins, we performed
immunoprecipitation experiments using agarose beads coated with
a cAMP analog, Sp-2-AEA-cAMPS-Agarose (Biolog) (see Meth-
ods). We used lysates from NCM460 cells transfected with our
sponge constructs, or as controls, untransfected cells. As shown in
figure 3a the cAMP sponge construct was enriched in the
precipitates (lane 6), while as expected, no binding was detected for
its mutant version (lane 5) or the untransfected cells (lane 4).
We also tested the cAMP-binding specificity in pull down assays
where increasing doses of exogenous cAMP competed with the Sp-
2-AEA-cAMPS coating the agarose beads. Both NCM460 and
HeLa cells were used because the latter express endogenous PKA-
RIb, making possible the comparison of our RIb-based chimeras
to the endogenous protein. Low concentrations of cAMP (0.5 mM-
2.5 mM) drastically reduced the binding of both the endogenous
PKA-RIb, and of cAMP sponge, which was completely abolished
at concentrations above 10 mM( Figure 3b and supplementary
Figure S1). In contrast, addition of 1 mMo r5mM of guanosine
39,5 9-cyclic monophosphate (cGMP) did not displace our
constructs (or the endogenous PKA-RIb) from the beads
(supplementary Figure S2). These experiments confirmed that
our construct specifically bound cAMP in vitro with roughly
submicromolar affinity, and that the mutant version lacked this
ability.
Figure 1. Schematic overview of the strategy used for the generation of cAMP sponge constructs. We cloned the PKA-RIb C-terminus
(AA 133–380), purposely omitting the PKA catalytic inhibitory domain located at N-terminus (AA 90–100). This construct was tagged at its C-terminus
with the improved far-red fluorescent protein, mCherry (DNH2PKARIb-mCherry). In order to generate a cAMP sponge that was specifically localized to
the cytoplasm, we appended the nuclear exclusion signal sequence (NES: ALPPLERTLTL) at the N-terminus, generating NESDNH2PKARIb-mCherry
(NES-cAMP sponge). Finally, in order to obtain a cAMP-resistant sponge we mutated the four critical cAMP-binding amino acids in the construct
NESDNH2 E202G, R211G, E226G, R335G PKARIb-mCherry, which we called mut-NES-cAMP sponge.
doi:10.1371/journal.pone.0007649.g001
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and (B) Ds-Red antibody that recognizes mCherry. (C) Confocal photomicrographs of NCM460 cells co-expressing cAMP ‘‘sponges’’ (mCherry) and a
nuclear-targeted EYFP (nuc-EYFP). The chimera named cAMP sponge was present throughout the cell without a specific subcellular localization. The
addition of an amino terminus nuclear exclusion signal sequence caused the constructs NES-cAMP sponge and its mutant (mut-NES-cAMP sponge)
version to be confined within the cytoplasm. Figures are representative of three biological replicates, and the observed localization efficiency was
always more that 85% of the cells.
doi:10.1371/journal.pone.0007649.g002
Figure 3. Cyclic AMP sponge is able to bind cAMP in vitro. (A) NCM460 cell lysates immunoprecipitated (IP) using Sp-2-AEA-cAMPS-Agarose
beads (Sp-cAMPS): lanes 1–3: input, 4–6: IP, 4: untransfected, 5: mut-NES-cAMP sponge, 6: NES-cAMP sponge. (B) cAMP competitive assay, HeLa cell
lysates, lanes 1–3: input, 4–14: IP, 4–8: untranfected, 9: mut-NES-cAMP sponge, 10–14: NES-cAMP sponge, lanes 8 and 14: beads only. Loading control:
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
doi:10.1371/journal.pone.0007649.g003
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We used the FRET-based cAMP sensor ‘‘Epac H30’’ which is
built around the native cAMP-binding protein Epac in order to
assess the effectiveness of our buffers at the single cell level[15,16].
These experiments were conducted in NCM460 and HEK293 cell
lines stably expressing the Epac H30 sensor (see Methods). These
cells were transiently transfected with cAMP sponge, and cAMP
responses of single, isolated sponge-transfected cells (identified by
mCherry fluorescence) were directly compared to neighboring
control cells in the same microscope field. As shown in Figure 4a
all controls responded to prostaglandin E2 (PGE2, black line),
while the sponge-expressing cells (red line) typically gave no
response. Of 19 isolated sponge-expressing cells examined in 11
experiments, there were four cells that did respond weakly to
PGE2, but with a .3-fold time delay as compared to the controls
(supplementary Figure S3). Supra-maximal doses of forskolin
(FSK; a nonspecific adenylyl cyclase activator) combined with the
general phosphodiesterase inhibitor isobutylmethylxanthine
(IBMX), caused the cAMP sponge to eventually become saturated,
yielding a response similar to isolated control cells. Similar
experiments were performed using HEK293 cells (supplementary
Figure S4). In contrast, isolated HEK293 cells (Figure 4b;
typical of 33 control, 6 cAMP sponge cells in 5 experiments), and
NCM460 cells (supplementary Figure S5; 74 controls, 10 cAMP
sponge cells in 6 experiments) expressing the mutant cAMP
sponge showed no significant differences in the amplitude or
timing of the response as compared to the controls.
As a further control to confirm that the Epac H30 FRET sensor
was competent to respond to cAMP in the sponge-expressing cells,
we used a cell-permeable Epac-specific cAMP analog, 8CPT-
2Me-cAMP (8-(4-chloro-phenylthio)-29-O-methyladenosine-39,59-
cyclic monophosphate)[17]. This compound binds to native Epac
and the Epac H30 sensor, but not to the PKA-RIb. We therefore
expected that the PKA-RIb-based cAMP sponge would not
recognize 8CPT-2Me-cAMP. In fact, no differences between
control and sponge-expressing cells were observed when the cells
were treated with the Epac-specific analog, whereas the response
to an elevation in native cAMP was clearly affected (Figure 4c;4 1
controls, 10 cAMP sponge cells in 5 experiments).
Overexpression of cAMP Sponge Blocks the Activation of
the Main cAMP Effector, PKA
We next examined whether cAMP sponge, by damping free
[cAMP], would also attenuate the activation of PKA during
agonist stimulation. For this purpose, we used two genetically
encoded sensors, AKAR2 and AKAR3 (gifts of Roger Tsien and
Figure 4. cAMP sponge abolishes agonist-induced cAMP signals and downstream activation of PKA. (A) Experiments in NCM460 cells
stably expressing cAMP sensor EpacH30. Cells transiently expressing NES-cAMP sponge (identified by mCherry; red trace) showed significant
attenuation of PGE2-induced cAMP signals as compared to control cells in same field (black trace; mean 6 SEM of 6 cells), typical of 78 controls, 19
cAMP sponge cells in 11 experiments. (B) HEK293 cells expressing mut-NES-cAMP sponge (red line) showed no significant differences as compared to
control cells (black trace; mean of 4 cells). Inset: time to peak of PGE2 response; paired data of 33 controls, 6 mut-NES-cAMP sponge 5 experiments,
n.s. (C) NCM460 cells treated with the cell permeable EPAC-specific cAMP analog (8-(4-chloro-phenylthio)-29-O-methyladenosine-39,59-cyclic
monophosphate. (D) NCM460 cells expressing AKAR3 plus NES-cAMP sponge (red trace) showed no PKA activation due to PGE2 challenge, in contrast
to controls expressing AKAR3 alone in the same field (black and gray traces).
doi:10.1371/journal.pone.0007649.g004
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change in FRET. These sensors do not bind cAMP directly. As
shown in Figure 4d, NCM460 cells transfected with AKAR3
alone responded normally to PGE2 stimulation, while neighboring
cells co-expressing AKAR3 and the cAMP sponge showed no
significant FRET response, indicating a lack of PKA activity. As
expected FSK plus IBMX eventually saturated the buffer,
restoring the PKA activity in the sponge-expressing cells (typical
of 10 controls, 10 sponge cells in 6 experiments). These data
provide independent confirmation that cAMP sponge can
effectively dampen cAMP signaling, measured as a loss of
activation of the major downstream target of the cAMP signal,
PKA.
cAMP Sponge-Expressing Cells Serve as a Sink for cAMP
Generated in Neighboring Cells Connected via Gap
Junctions
The coordinated physiological activity of many tissues relies on
cell-to-cell transfer of metabolites, electrical signals, and second
messengers (including cAMP) via gap junctions[20,21]. Imaging
studies using FRET-based sensors have shown that cAMP levels
in individual cells follow those of the surrounding cells due to
diffusion through these junctions[20,21]. We questioned how the
presence of the cAMP buffer would affect the agonist-stimulated
cAMP signal when buffer-expressing cells were physically
connected to non-transfected controls. To this aim we sought
out couplets of NCM460 cells in the microscope field in which
one of the cells expressed the cAMP sponge construct and the
other did not (control cell). Time-lapse images of the Epac H30
FRET ratio during agonist stimulation suggested that the control
cells were acting as a source of cAMP, while the connected
buffer-expressing cells served as a sink for the second messenger
(supplementary Movie S1). As shown in Figure 5a, under these
conditions there was a significant delay in the PGE2 response,
averaging ,50 seconds in the cAMP sponge cells, compared to
untransfected controls (49 controls, 11 mCherry cells, 9
experiments p,0.0005).
Pretreatment with the reversible gap junction blocker 18a-
glycyrrhetinic acid[22] inhibited the cell-to-cell transfer of cAMP,
and this was translated into a doubling of the delay in the agonist
response observed in cAMP sponge-expressing cells. When 18a-
glycyrrhetinic acid was rinsed away, the cAMP transfer from
controls to buffer expressing cells was rescued, with a significantly
shorter delay in the response (Figure 5b; 46 controls, 10 cAMP
sponge cells in 6 experiments). It is noteworthy that the amplitude
and time course of the cAMP response in the control cell was the
same independent of whether cAMP was permitted to diffuse into
the buffer-expressing cell via the 18a-glycyrrhetinic acid-depen-
dent pathway. This would suggest that second messenger
produced in one cell is able to compensate for a lagging cell,
otherwise the cAMP response in the control cell would have been
larger in the presence of the gap junction inhibitor.
Figure 5. Transfer of cAMP from control cells to connected buffer expressing cells through gap junctions. (a) NCM460 cells expressing
NES-cAMP sponge (red line) connected to control cells (black line; mean of 4 cells), showed a small delay (time to peak) in the PGE2 response (inset:
mean 6 s.e.m. of 49 controls, 11 NES-cAMP sponge in 9 experiments). (b) Pre-incubation with the gap-junction inhibitor 18a-glycyrrhetinic acid (18a-
GRA) significantly increased the time to peak of the buffer expressing cells. Inset: summary of 46 controls, 10 cAMP sponge cells in 6 experiments
(* p,0.05; *** p,0.001; **** p,0.0001). See also supplementary Movie S1.
doi:10.1371/journal.pone.0007649.g005
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The introduction of cell-permeant calcium chelators such as
BAPTA-AM (1,2-bis(o-aminophenoxy)ethane-N,N,N’,N’-tetraace-
tic acid, acetoxymethyl ester) by Roger Tsien in the early 1980’s
[23,24] revolutionized the study of Ca
2+ signaling. This high
affinity Ca
2+ chelator can be loaded non-invasively into living cells,
and used to rapidly clamp [Ca
2+] in the cytosol to resting levels
during agonist activation. This invaluable tool permitted investi-
gators to dissect out the relative importance of the Ca
2+ spike in
complex systems involving concurrent activation of multiple
signaling pathways. Low-affinity Ca
2+ buffers such as N,N,N’,N’-
tetrakis (2-pyridylmethyl)ethylene diamine or TPEN, used previ-
ously to clamp [Ca
2+] within endoplasmic reticulum Ca
2+
stores[25], have also proven useful for reversibly manipulating
free [Ca
2+] within subcellular compartments.
Uchiyama and colleagues extended this concept by generating
the first genetically encoded buffer for inositol 1,4,5-trisphosphate
(IP3). This construct (named ‘‘IP3 sponge’’)[26] was based on a
hyperaffinity IP3 binding fragment derived from the type I IP3
receptor. Surprisingly, to date no such tool has been described for
the ubiquitous intracellular second messenger, cAMP, prompting
us to develop the ‘‘cAMP sponge’’ constructs described here.
In order to be effective as a buffering molecule, the affinity of a
cAMP sponge should be somewhat less than the resting free levels
of cAMP (maintained by the constitutive action of PDEs),
otherwise the buffer molecule would be saturated prior to
stimulation. It should be able, however, to compete with
endogenous effectors of the cAMP signal, e.g. Epac, PKA, and
cyclic nucleotide-gated channels. Recent work by Døskeland and
colleagues has shown that the cAMP affinity of the PKA
holoenzyme and Epac are similar (about 2.9 mM), but that the
isolated RIa has about three orders of magnitude higher affinity
for cAMP (<0.9 nM) [9]. While native PKA-RI subunits could
potentially act as endogenous high affinity soluble cAMP buffers,
free regulatory subunits are rarely found in the living cell because
their expression levels are tightly controlled in a 1:1 ratio with
those of PKA-C [27,28].
In our study, we constructed a cAMP buffer based on the
tandem cAMP-binding domains of the isolated PKA-RIb. This
truncated form of RIb is unable to bind the PKA catalytic subunit
or to dimerize with itself. Our construct was shown to bind cAMP
in vitro with roughly submicromolar affinity, and was insensitive to
cGMP. The fragment was tagged with a fluorescent protein
variant, mCherry, which is spectrally compatible with the CFP
and YFP of FRET-based sensors for cAMP. This permitted
correlation of the concentration of the expressed buffer (a function
of mCherry fluorescence intensity) with its actions on cAMP
signaling as measured by an Epac- and FRET-based cAMP sensor
[16] in single cells. We were also successful in targeting our
construct to the cytoplasm using a classic nuclear exclusion signal,
proving its suitability for sub-cellular localization. Finally, the
introduction of four point mutations led to the generation of a
double mutant version unable to bind cAMP, which has provided
an optimal control.
We validated cAMP sponge at the single cell level using a
FRET-based imaging approach and demonstrated that it was able
to block agonist-induced cAMP elevations (EPAC H30, figure 4a–
c) and the downstream PKA activation (AKAR3, Figure 4d). In
contrast, in experiments performed using the mutant version of
our sponge, no significant effect on the cAMP signal was
measured.
To illustrate a practical application for this tool, we probed the
effect of the cAMP buffer on intercellular transfer of cAMP via gap
junctions by analyzing couplets of NCM460 colonic epithelial cells
in which only one of the two cells expressed the cAMP sponge.
Our data suggest that during agonist challenge, control cells
produced extra cAMP that diffused into neighboring cells until the
additional buffering capacity of the expressed sponge construct
was overwhelmed, leading to a detectable elevation of free cAMP.
These data bring to light the intriguing possibility that some type
of feedback regulation allows cAMP to control its own permeation
through gap junctions. It is known, for example, that PKA can
phosphorylate certain connexin proteins (the elemental compo-
nents of the gap junction), leading to alterations in gap junction
permeability[29,30]. This could potentially provide a mechanism
that allows cells to ‘‘sense’’ the lack of free second messenger in one
cell, and compensate by increasing the sharing of cAMP via this
pathway. It is perhaps relevant that agonist-activated cAMP
signals of individual NCM460 cells within coupled cell clusters
were highly homogenous with respect to amplitude and time
course under control conditions, but were strikingly heterogeneous
in the presence of gap junction inhibitors (KL and AMH,
unpublished observations). These observations would be consistent
with a role for gap junction-mediated sharing of cAMP in
‘‘normalizing’’ the signal across epithelial sheets.
The second messenger concept, as proposed many decades ago,
originally portrayed global, uniform elevations of Ca
2+ and cAMP
as simple on/off switches for controlling cell function. Sophisti-
cated tools for monitoring and manipulating the Ca
2+ signal
(including Ca
2+ buffers) showed, however, the functional impor-
tance of highly localized, elementary Ca
2+ signaling events (Ca
2+
sparks, puffs, and blips). Does something akin to a ‘‘cAMP spark’’
also exist, and does it encode unique information? While recent
data have pointed to the existence of privileged cAMP signaling
microdomains which have the potential to differentially control
cellular functions[6], the development of tools to selectively
perturb these signals has not kept pace with this rapidly expanding
area of investigation. The possibility to clamp [cAMP] in highly
localized subcellular microdomains using targeted ‘‘cAMP
sponge’’ constructs described here should prove useful for
interrogating this previously inaccessible aspect of the cAMP
signal transduction process.
Materials and Methods
Reagents
Guanosine 39,5 9-cyclic monophosphate (cGMP) and 8CPT-
2Me-cAMP (8-(4-chloro-phenylthio)-29-O-methyladenosine-39,5 9-
cyclic monophosphate) were obtained from Calbiochem (San
Diego, CA). 2- (2- Aminoethylamino) adenosine- 39,5 9- cyclic
monophosphorothioate, Sp- isomer, (Sp-2-AEA-cAMPS-Agarose)
was obtained from Biolog (Biolog, Hayward CA). All restriction
enzymes were purchased from New England Biolabs (Ipswich,
MA). Primers were custom made by Invitrogen (Carlsbad, CA). All
other reagents were from Sigma (St Louis, MO) unless otherwise
noted.
Cell Culture and Transfection
HeLa and human embryonic kidney (HEK293) cells (ATCC)
were grown in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum. NCM460 cells were
obtained by a licensing agreement from INCELL Corporation,
LLC, (San Antonio TX), and grown in M3:10 medium (INCELL)
according to the supplier’s recommendations. HEK293 and
NCM460 cell lines stably expressing the cAMP sensor Epac
H30 were generated by repeated rounds of sorting using FACS
(fluorescence activated cell sorter; Beth Israel Deaconess Medical
Cyclic AMP Sponge
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transfected using Effectene transfection reagent (Qiagen, Valencia,
CA) according to the manufacturer.
Expression Plasmids and Mutagenesis
To generate the cAMP sponge constructs, we used specific
primers in polymerase chain reactions (PCR) to amplify amino
acids 132 to 381 of the human PKA regulatory subunit Ib (PKA-
RIb; Origene clone TC 124688, NM_002735). We used Pfu Ultra
High-fidelity DNA Polymerase (Stratagene, La Jolla, CA), with the
following primers carrying a 59 Bam HI restriction enzyme sites
(underlined): Primer Forward 59-GTGGATCCAATCTCCAA-
GAACGTGCTCTTC-39, primer Reverse 59-GTGGATCCGC-
GACGGTGAGGGAGATGAAGCT-39. The PCR product after
digestion was subcloned in frame with mCherry into the vector
pcDNA3.
The Nuclear Export Signal (NES: ALPPLERTLTL)[10] was
added at the N-terminus to obtain cytoplasmic (non-nuclear)
localization of our construct. Two rounds of site directed
mutagenesis (Quickchange XL; Stratagene La Jolla, CA) gener-
ated the four point mutations (E202G, R211G, E326G, R335G)
that altered the critical cAMP binding residues for both binding
sites. All constructs were sequenced (Dana Farber DNA Resource
Core, Boston MA).
Confocal Imaging
NCM460 cells were seeded on glass coverslips and after
24 hours were co-transfected with equal amounts of cAMP sponge
constructs and an enhanced Yellow Fluorescent Protein targeted
to the nucleus (nuc-EYFP). Twenty-four to forty-eight hours after
transfection, the coverslips were mounted in a home-built flow
through perfusion chamber. Cells bathed in HEPES-buffered
Ringer’s solution were imaged under a 60X oil immersion
objective on a Nikon Confocal Microscope C1. Images were
collected using the EZ-C1 software (Nikon).
Western Blot and Immunoprecipitation
HeLa or NCM460 cells were transfected with equal amounts of
(NES) cAMP sponge or mutant (NES) cAMP sponge. Twenty-four
hours after transfection, cells were lysed using RIPA buffer (Sigma)
complemented with protease inhibitors cocktail (Sigma) or
SolObuffer (FabGennix Inc., Frisco, TX) complemented with
protease inhibitor cocktail (FabGennix Inc.). Cell lysates were
sonicated and insoluble material was removed by centrifugation at
14,000 g for 10 min at 4uC. For immunoprecipitation experiments
100 mg–200 mg of NCM460 or HeLa lysates were incubated for
2 h at 4u with 25 ml of agarose beads coated with the PDE-
resistant cAMP analog 2- (2- Aminoethylamino) adenosine- 39,5 9-
cyclic monophosphorothioate, Sp-isomer, (Sp-2-AEA-cAMPS-
Agarose; from Biolog, Hayward CA). Beads were washed three
times with ice-cold PBS and the proteins were released with 25 ml–
35 ml of 2x SDS-loading buffer. Equal amount of immunoprecip-
itated proteins or total cell lysates were resolved on 5%–20% tris-
glycine SDS/PAGE gels and electroblotted onto PVDF mem-
branes (Hybond-P, Amersham Biosciences, Piscataway, NJ). After
transfer PVDF membranes were blocked for 1 h at room
temperature in 5% milk with Tris-buffered saline/Tween 20
(TBST; 10 mM Tris HCl, pH 8.0/150 mM NaCl/0.1% Tween
20). Next the membranes were incubated for 2 h at room
temperature with an anti-PKA-RIb antibody (c19, Santa Cruz
Biotechnology Inc., Santa Cruz, CA) or an anti-DS-red antibody
that also recognizes mCherry (Clontech, Mountain View, CA).
Both primary antibodies were diluted 1:1000 in 5% milk-TBST.
After four washes with TBST, membranes were incubated at room
temperature for 1 h with a peroxidase-conjugated secondary
antibody (1:2000; Santa Cruz). Peroxidase activity was detected
with enhanced chemiluminescence (ECL advance western blotting
detection kit, Amersham Biosciences). Glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) antibody (1:2000; Santa Cruz)
was used as a loading control for the total cell lysates and to detect
protein contamination for the immunoprecipitated proteins.
Ratio Imaging
Real-time FRET imaging experiments were performed using a
fluorescence imaging system built around a Nikon TE200
microscope as previously described[31]. Metafluor software
(Molecular Devices, Downingtown, PA) was used to control filter
wheels (Sutter Instruments, Novato, CA) placed in the excitation
and emission path, and to acquire ratio data. Cells were seeded on
glass coverslips and were transfected 24 hours later. The following
day, we mounted the coverslips in a home-built flow through
perfusion chamber, and imaged the cells using a 40X oil
immersion objective. Cells were bathed in HEPES-buffered
Ringer’s solution containing (in mM): 125 NaCl, 25 HEPES, 10
Glucose, 5 K2HPO4, 1 MgSO4 and 1 CaCl2, pH=7.40. The
485 nm/535 nm FRET emission ratios from the Epac-based
cAMP sensor (440 nm excitation) were acquired every 10 seconds.
PKA phosphorylation activity was expressed as the 535 nm/
485 nm FRET emission ratios of AKAR2 or AKAR3 (440 nm
excitation). The fluorescence of mCherry (excitation 585 nm,
emission 610 nm) did not interfere with either of these
measurements as previously reported[32].
Supporting Information
Figure S1 Cyclic AMP competitive assay. Lysates from
NCM460 cells transfected with NES-cAMP sponge, its mutant
variant, and untransfected cells were immunoprecipitated using
Sp-2-AEA-cAMPS-Agarose (Sp-cAMPS) with increasing concen-
trations of exogenous cAMP. Lanes 1–7: IP supernatants; lane 8:
IP untransfected; lane 9: mut-NES-cAMP sponge; lanes 10–14:
NES-cAMP sponge lane 14: beads only. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used to assess protein
loading and contamination.
Found at: doi:10.1371/journal.pone.0007649.s001 (3.00 MB TIF)
Figure S2 Cyclic GMP competitive assay. HeLa total cell lysates
immunoprecipitated (IP) using Sp-2-AEA-cAMPS-Agarose beads
(Sp-cAMPS) in the presence of increasing concentrations of
cGMP: lanes 1–6: supernatants, 7–12: IP, lane 7: untransfected, 8:
mut-NES-cAMP sponge, 9–12: NES-cAMP sponge. Addition of
1–5 mM of exogenous cGMP did not affect the binding of the
buffer or the endogenous RIb to Sp-cAMP, when the cGMP
concentration was increased to 100 mM the binding of both (RIb
and buffer) was affected.
Found at: doi:10.1371/journal.pone.0007649.s002 (3.00 MB TIF)
Figure S3 Delayed cAMP response in buffer-expressing
NCM460 cells. In a subset of NCM460 cells stably expressing
cAMP sensor EpacH30 transfected with (NES) cAMP sponge (red
trace) there was a small response but this occurred with a 3 fold
delay in the time to peak as compared to controls in same field
(black trace). Typical of 4 (NES) cAMP sponge cells out of 19 in 11
experiments. Upon addition of the cell-permeable EPAC-specific
cAMP analog 8-CPT-29 Me-cAMP, (NES) cAMP sponge-
expressing cells responded similarly to the controls.
Found at: doi:10.1371/journal.pone.0007649.s003 (3.00 MB TIF)
Figure S4 Expression of cAMP sponge blocks agonist-induced
cAMP signals in HEK293 cells. Isolated NES-cAMP sponge-
Cyclic AMP Sponge
PLoS ONE | www.plosone.org 7 November 2009 | Volume 4 | Issue 11 | e7649expressing cells (identified by mCherry; red trace) showed no
response to PGE2 compared to the untransfected controls (black
trace; mean of 6 cells) on the same coverslip. On the other hand
cells expressing the buffer that were connected to control cells (red
trace) showed a significant delay of the response but eventually
responded, indicating the saturation of the buffer. A combination
of forskolin (FSK 50 mM) and IBMX (1 mM) saturated the buffer,
producing responses similar to the controls (representative data of
28 controls, 8 cAMP sponge in 5 experiments).
Found at: doi:10.1371/journal.pone.0007649.s004 (3.00 MB TIF)
Figure S5 The mutant cAMP sponge does not influence the
kinetics of PGE2-induced responses. Bar graph indicating PGE2
responses of NCM460 cells expressing mutant (NES) cAMP
sponge and controls in the same field. No significant difference was
detected (74 controls, 10 cAMP sponge cells in 6 experiments)
between the two groups.
Found at: doi:10.1371/journal.pone.0007649.s005 (3.00 MB TIF)
Movie S1 Vectorial transfer of cAMP between connected cells.
NCM460 cells stably expressing the EpacH30 cAMP sensor were
transiently transfected with cAMP sponge. Here the microscope
field contained an isolated control cell (on the left) and a couplet of
cells in which only one cell expressed the sponge construct (on the
right). The image sequence shows a significant delay in the PGE2
response of the coupled sponge-expressing cell compared to the
two controls, with an apparent transfer of cAMP from the control
(top cell in couplet) to the cell expressing the cAMP sponge
(bottom). Time-lapse images represent pseudo-color of EpacH30
480 nm/535 nm FRET emission ratio, one frame every 10
seconds, total experiment duration 5.5 minutes.
Found at: doi:10.1371/journal.pone.0007649.s006 (1.40 MB AVI)
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